tiprankstipranks
Protagenic Therapeutics, Inc. (PTIX)
:PTIX
US Market

Protagenic Therapeutics (PTIX) Financial Statements

Compare
37 Followers

Protagenic Therapeutics Financial Overview

Protagenic Therapeutics's market cap is currently $2.42M. The company's EPS TTM is $-1.274; its P/E ratio is ―; Protagenic Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -28.22K$ -30.00$ 0.00$ -286.00$ -339.00
Operating Income$ -4.53M$ -3.56M$ -4.14M$ -2.55M$ -2.09M
EBITDA$ -4.50M$ -3.42M$ -4.14M$ -2.55M$ -2.09M
Net Income$ -5.00M$ -3.60M$ -4.99M$ -2.79M$ -1.77M
Balance Sheet
Cash & Short-Term Investments$ 4.06M$ 7.98M$ 10.37M$ 671.09K$ 798.62K
Total Assets$ 4.32M$ 8.04M$ 11.06M$ 879.25K$ 842.27K
Total Debt$ 0.00$ 344.23K$ 318.43K$ 1.37M$ 279.37K
Net Debt$ -1.29M$ 129.04K$ -222.74K$ 702.71K$ -519.25K
Total Liabilities$ 655.25K$ 1.12M$ 1.12M$ 2.03M$ 1.48M
Stockholders' Equity$ 3.67M$ 6.92M$ 9.94M$ -1.15M$ -634.37K
Cash Flow
Free Cash Flow$ -3.85M$ -2.00M$ -2.80M$ -1.35M$ -487.99K
Operating Cash Flow$ -3.70M$ -1.99M$ -2.80M$ -1.35M$ -487.99K
Investing Cash Flow$ 4.78M$ 1.60M$ -9.91M$ 0.00$ 250.00K
Financing Cash Flow$ 0.00$ 0.00$ 12.58M$ 1.22M$ 670.00K
Currency in USD

Protagenic Therapeutics Earnings and Revenue History

Protagenic Therapeutics Debt to Assets

Protagenic Therapeutics Cash Flow

Protagenic Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis